|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.2269 - 0.2634|
|52 Week Range||0.2269 - 3.4900|
|Beta (3Y Monthly)||1.95|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Following an equity payment default by Emerald Health Therapeutics (OTCQB: EMHTF) under the Delta 2 option agreement involving Pure Sunfarms, Village Farms International (TSX: VFF) (NASDAQ: VFF) has informed Pure Sunfarms of exercising its rights to increase its ownership in Pure Sunfarms and advanced an equity payment to Pure Sunfarms of $5.94 million. Emerald was obligated to […]The post Village Farms Eyes Increased Position in Pure Sunfarms appeared first on Market Exclusive.
Cannabis Stocks Sink as Market Sentiment DampensCannabis-sector ETFsThe cannabis sector has broadly fallen today as overall market sentiment has been dampened by US-China trade disputes. The Horizons Marijuana Life Sciences ETF (HMMJ) and the
Cannabis Sector Extended Its Losses Last Week(Continued from Prior Part)Cannabis stocks fellLast week, most of the stocks in the cannabis sector ended lower. The Horizons Marijuana Life Sciences ETF (HMMJ) fell ~1.2%, while the ETFMG Alternative
How Medical Marijuana Stocks Performed on April 4(Continued from Prior Part)Medical marijuana stocks The cannabis sector saw some weakness on April 4. The ETFMG Alternate Harvest ETF (MJ) saw a negative price action of 0.11%. Charlotte’s Web
Why Jim Cramer Likes Canopy Growth(Continued from Prior Part)Recurring themeJim Cramer has mentioned that alcoholic beverage companies are at risk due to growth in the cannabis sector (MJ).Jefferies echoed Cramer’s viewOn February 25, another
Jefferies Initiates Coverage of CGC, TRST, ACB, OGRMF, and MoreJefferies initiates coverage on cannabisJust last week, we saw Seaport Global initiate coverage on some of the big cannabis players in the industry. Early this morning, yet another firm
Investors (MJ) have even lost money in Aphria (APHA), Emerald Health (EMHTF), and Aurora Cannabis (ACBFF), which have lost 64%, 60%, and 37% during the same period, respectively. Analysts’ consensus target price for Supreme Cannabis remained unchanged month-over-month at 3.63 Canadian dollars. The stock closed at ~1 Canadian dollars on December 19, which was at a discount of nearly 72.5%.